IBIOBA - MPSP   22718
INSTITUTO DE INVESTIGACION EN BIOMEDICINA DE BUENOS AIRES - INSTITUTO PARTNER DE LA SOCIEDAD MAX PLANCK
Unidad Ejecutora - UE
artículos
Título:
Molecular and cellular pathogenesis of pituitary tumors
Autor/es:
RENNER, ULRICH; ELGUERO, MARIA BELEN; STALLA, GÜNTER K.; ARZT, EDUARDO
Revista:
Current Opinion in Endocrine and Metabolic Research
Editorial:
Elsevier
Referencias:
Lugar: Ámsterdam; Año: 2018 vol. 1 p. 1 - 8
ISSN:
2451-9650
Resumen:
Pituitary tumors occur sporadically (95%) or as hereditarytumors, either associated with endocrine syndromes (2.5%) oras familial isolated variants (FIPA, 2.5%). In sporadic pituitarytumors, in addition to the known somatotropic GNAS mutation,a recurrent mutation of the USP8 gene was recently detectedin corticotropinomas. Thus variable genetic and epigeneticmodifications may mostly be responsible for pituitary tumorigenesis. However, these different changes seem to modifycommon intracellular targets such as distinct tumor suppressors, cell cycle checkpoints or signaling pathways. Thus,recurrently impaired functions in concert with/or recurrentlyimpaired genes may trigger pituitary tumorigenesis. This mayalso be of relevance for the different steps involved in pituitarytumor progression such as angiogenesis, invasiveness, pituitary tumor senescence and pituitary carcinoma formation.